Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in IDXX — Idexx Laboratories Inc /De

CIK 1595888 NEW YORK, NY
Back to IDXX Full portfolio

Position in IDXX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$55,333,055
+$46,905,830 QoQ
Shares Held
105,108
+600.8% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#106
of 1,286 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IDXX Over Time

Shares Held

Position Value (USD)

Derivatives in IDXX

reported options exposure · as of Jun 30, 2026
CallValue
$5,843,484
CallShares
11,100
PutValue
$2,895,420
PutShares
5,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $950,850,693 across 33 Diagnostics & Research names. IDXX ranks #6 (5.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 1,783,444 $267,570,103
2 NTRA
Natera, Inc.
 926,986 $251,630,349
3 ILMN
Illumina, Inc.
 372,628 $65,519,180
4 ICLR
Icon PLC
 374,800 $65,106,507
5 RVTY
Revvity, Inc.
 576,014 $64,087,317
6 IDXX
Idexx Laboratories Inc /De
This page 		105,108 $55,333,055
7 IQV
Iqvia Holdings Inc.
 282,508 $54,586,195
8 DHR
Danaher Corp /De/
 189,123 $36,024,147

All Filings in IDXX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,843,484 11,100
2026-06-30 $2,895,420 5,500
2026-06-30 $55,333,055 105,108
2026-03-31 $5,394,144 9,600
2026-03-31 $5,450,333 9,700
2026-03-31 $8,427,225 14,998
2025-12-31 $9,877,338 14,600
2025-12-31 $6,098,240 9,014
2025-12-31 $22,190,184 32,800
2025-09-30 $20,952,397 32,795
2025-09-30 $6,133,344 9,600
2025-09-30 $26,705,602 41,800
2025-06-30 $11,692,212 21,800
2025-06-30 $4,397,988 8,200
2025-06-30 $7,095,241 13,229
2025-03-31 $3,175,241 7,561
2025-03-31 $5,627,330 13,400
2025-03-31 $10,750,720 25,600
2024-12-31 $3,762,304 9,100
2024-12-31 $10,973,111 26,541
2024-12-31 $16,082,816 38,900
2024-09-30 $20,562,454 40,700
2024-09-30 $1,175,646 2,327
2024-09-30 $7,325,690 14,500
2024-06-30 $20,970,061 43,042
2024-03-31 $12,557,151 23,257
2023-12-31 $14,522,882 26,165
2023-09-30 $5,442,262 12,446
2023-06-30 $15,104,566 30,075
2023-03-31 $7,781,244 15,560
2022-12-31 $12,449,715 30,517
2022-09-30 $6,527,728 20,036
2022-06-30 $22,486,000 64,112
2022-03-31 $13,184,146 24,100
2022-03-31 $12,199,438 22,300
2022-03-31 $3,914,760 7,156
2021-12-31 $12,642,432 19,200
2021-12-31 $42,338,978 64,300
2021-12-31 $11,145,092 16,926
2021-09-30 $12,712,879 20,442
2021-09-30 $45,212,130 72,700
2021-09-30 $36,318,960 58,400
2021-06-30 $42,377,005 67,100
2021-06-30 $12,079,025 19,126
2021-06-30 $16,672,920 26,400
2021-03-31 $11,596,647 23,700
2021-03-31 $12,091,827 24,712
2021-03-31 $7,241,788 14,800
2020-12-31 $18,345,229 36,700
2020-12-31 $3,543,577 7,089

Report a Problem

Category
Description
Email (optional, for follow-up)